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Abstract During human foetal brain vascularization,
activated CD31?/CD105? endothelial cells are character-
ized by the emission of filopodial processes which also
decorate the advancing tip of the vascular sprout. Together
with filopodia, both the markers also reveal a number of
plasma membrane-derived microvesicles (MVs) which are
concentrated around the tip cell tuft of processes. At this
site, MVs appear in tight contact with endothelial filopodia
and follow these long processes, advancing into the sur-
rounding neuropil to a possible cell target. These obser-
vations suggest that, like shedding vesicles of many other
cell types that deliver signalling molecules and play a role
in cell-to-cell communication, MVs sent out from endo-
thelial tip cells could be involved in tip cell guidance and/
or act on target cells, regulating cell-to-cell mutual recog-
nition during vessel sprouting and final anastomosis. The
results also suggest a new role for tip cell filopodia as
conveyor processes for transporting MVs far from the cell
of origin in a controlled microenvironment. Additional
studies focused on the identification of MV content are
needed to ultimately clarify the significance of tip cell MVs
during human brain vascularization.
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Introduction
Exosomes and other plasma membrane-derived vesicles,
known as ectosomes, shed vesicles, or microvesicles (MV),
are secreted by many different cell types and are thought to
play important roles in cell–cell communication by
releasing various active molecules including signalling
molecules, mRNAs, and miRNAs, in both physiological
and pathological processes. In blood, as ‘microparticles’, in
seminal fluid, as ‘prostasomes’, or within the tissue mi-
croenviroment, plasma membrane-derived MVs bridge the
space between distant cells, having a role in cell-to-cell
communication during development as well as in inflam-
matory responses and tumour growth. At the the recipient
cell surface, shed MVs find specific ligands, become
internalized and enter the endocytic pathway or directly
fuse with the plasma membrane and release their content
within the cytoplasm. Unlike exosomes that form in
endosomal compartments and have a diameter size of
100 nm or less, microvesicles have a larger diameter, from
100 to 1.000 nm, and directly originate from plasma
membrane protrusions, then detach from the cell surface
(reviewed in [1–3]).
Recent studies ‘in vitro’ and ‘in vivo’ have demon-
strated that platelet- and tumour cell-derived MVs can
participate in angiogenic events by transferring a series of
proangiogenic factors, including growth factors (VEGF,
bFGF, PDGF), chemokine receptors (CCR5, CXCR4), and
matrix metalloproteinases (MMP2, MMP9), which all have
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endothelial cells and/or endothelial progenitor cells (EPCs)
as target cells and contribute to regulate vessel repair,
sprouting, and invasiveness by inducing intracellular sig-
nalling, following binding to receptors or by genetic
transfer (reviewed in [4, 5]). After their internalization in
endothelial cells, MVs derived from EPCs promote angi-
ogenesis, activating the formation of capillary-like struc-
tures through the PI3 K/AKT signalling pathway [6].
Tumour cell shedding of MVs is positively correlated with
malignancy and induces endothelial cell migration and ‘in
vivo’ angiogenesis via vesicle-associated sphingomyelin
[7]. Also exosomes produced ‘in vitro’ by K562 chronic
myeloid leukemia cells trigger angiotube formation in
human umbilical endothelial cells (HUVECs) [8, 9] and
hypoxic glioblastoma cells elicit an angiogenic endothelial
cell phenotype by releasing an MV-associated tissue factor
involved in activation of the PAR-2/heparin-binding EGF-
like growth factor [10]. Endothelial cells themselves can
also release MVs, thus contributing together with other
stimuli to the angiogenic activity of growing microvessels.
Under VEGF and bFGF stimuli, cultured HUVECs shed
MMP/TIMP-containing MVs and are possibly involved in
the autocrine control of vessel growth [11]. This study,
carried out in developing human foetal brain by using high
resolution confocal microscopy and the endothelial mark-
ers CD31 and CD105, reveals shedding of CD31?/CD105?
MVs by endothelial cells of growing microvessels and the
presence of filopodia and associated MVs at the advancing
front of the sprout, where they may form a conveyor/
messenger apparatus of endothelial tip cells, possibly




Autopsy specimens of telencephalon were collected from 2
legally aborted foetuses (9–10 weeks of gestation, wg) and 2
foetuses spontaneously aborted due to preterm rupture of
the placental membranes (22 wg), with no history of
neurological pathologies. Permission to collect tissue was
obtained from the maternal donor at the end of the abortion
procedure. The sampling and handling of human specimens
conformed to the ethical rules of the Department of
Pathology, Medical School, University of Bari, Italy, and
approval was gained from the local Ethics Committee of the
National Health System in compliance with the principles
stated in the Declaration of Helsinki. The foetal age was
estimated on the basis of the crown-rump length and/or
pregnancy records (counting from the last menstrual
period). At autopsy, the selected foetuses did not reveal
macroscopic structural abnormalities and/or malformations
of the central nervous system. The dorso-lateral wall of the
telencephalic vesicles (future neocortex) was dissected and
fixed for 2–3 h at 4 C by immersion in 2 % paraformal-
dehyde plus 0.2 % glutaraldehyde solution. Specimens were
then washed in phosphate buffered saline (PBS, pH 7.6) and
serially sectioned by a vibrating microtome. 20-lm sections
were collected at regular intervals and processed for con-
ventional histological analysis with toluidine blue staining
to ascertain the absence of microscopic malformations; all
the other sections were stored in PBS plus 0.02 % parafor-
maldehyde for fluorescence immunolabeling.
Immunofluorescence and laser confocal microscopy
Single and multiple immunostainings were carried out with
the following primary antibodies: mouse IgG1k anti-Human
CD31 (diluted 1:10 in blocking buffer-PBS, 1 % bovine
serum albumin, 2 % FCS-BB; Dako Cytomation, Glostrup,
Denmark), rabbit polyclonal IgG anti-Human CD105 (pre-
diluted; Abcam, Cambridge, UK), rabbit polyclonal IgG
anti-NG2 (diluted 1:50 in BB; this affinity purified antibody
directed against the D2 domain of NG2 was a gift from W.
Stallcup, The Burnham Institute for Medical Research, La
Jolla, CA, USA), and mouse monoclonal IgG1k anti-Human
collagen type IV (diluted 1:100 in BB; Dako). After
allowing the sections to adhere on polylysine slides (Men-
zel-Glaser, GmbH, Braunschweig, Germany) by drying for
10 min at room temperature (RT), they were submitted to
the following protocols: rehydration with PBS for 5 min at
RT or microwave pre-treatment in 0.01 M citrate buffer (pH
6.0) for 15 min at 750 W (for CD105); incubation with
0.5 % Triton X-100 in PBS for 30 min at RT and with BB
30 min at RT; incubation with diluted single or combined
primary antibodies overnight at 4 C; incubation with
appropriate fluorophore-conjugated secondary antibodies
(anti-rabbit 555 and anti-mouse 555 diluted 1:400 in BB;
Invitrogen, Eugene, OR, USA) or biotinylated secondary
antibodies (diluted 1:400 in BB; Vector Laboratories Inc.;
Burlingame, CA, USA) followed by fluorophore-conjugated
streptavidin (488; diluted 1:400 in BB for 45 min at RT;
Invitrogen). After immunolabelling, the sections were fixed
in 4 % PFA for 10 min and counterstained with TO-PRO3
diluted 1:10 K in PBS for 5 min at RT (633; Invitrogen).
After each incubation step the sections were washed 3 times
for 5 min with PBS. Finally, the sections were coverslipped
with Vectashield (Vector) and sealed with nail varnish.
Negative controls were prepared by omitting the primary
antibodies, pre-adsorbing the primary antibodies with an
excess of antigen when available, and mismatching the
secondary antibodies. The stainings were examined under
the Leica TCS SP5 confocal laser-scanning microscope
(Leica Microsystems, Mannheim, Germany) using a
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sequential scan procedure. Confocal images were taken at
250 nm intervals through the z-axis of the sections. Con-
focal images were taken with 409 and 639 oil lenses.
Z-stacks of serial optical planes (projection images) and
single optical planes were analyzed by Leica confocal
software (Multicolour Package; Leica Microsystems). The
size of plasma-membrane vesicles was evaluated with LAS-
AF SP5 software (Leica Microsystems) on 639 magnifi-
cation fields zoomed 3 times. Microvesicles diameter (nm)
was measured on single optical planes from CD31- and
CD105-labeled sections (n = 8, 9–10 wg; n = 15, 22 wg)
for a total of 55 tip cell fields. The results were expressed as
mean ± SD.
Transmission electron microscopy
Small samples collected from the previously described
telencephalon specimens were submitted to electron
microscopy procedures. Briefly, samples were fixed in
0.1 M phosphate-buffered 3 % glutaraldehyde, post-fixed
in phosphate-buffered 1 % OsO4, dehydrated in serial
alcohols, and embedded in Epon 812. Ultrathin sections
were cut with an LKB V ultramicrotome, stained with
uranyl acetate and lead citrate, and observed under a CM
10 Philips electron microscope.
Results and discussion
At 9–10 weeks of gestation (wg), when the cerebral cortex
is formed by only few rows of neuroblasts (the pre-plate),
branches of the earliest penetrated telencephalic micro-
vessels lie at the border between the ventricular zone (VZ)
and the subventricular zone (SVZ), forming a primary
periventricular plexus. These microvessels are distinctly
labelled by the endothelial marker CD31 and also show a
discontinuous pericyte layer revealed by the pericyte-spe-
cific marker NG2 (Fig. 1). Endothelial long filopodial
processes arise from the ventricular side of these micro-
vessels, run right through the cells of the VZ and abut the
ventricular telencephalic surface (Fig. 1A). Throughout
the telencephalon wall, growing microvessels show active
endothelia characterized by long filopodia and abluminal
plasma membrane protrusions; membrane-derived MVs are
also recognizable and appear associated with the filopodial
processes (Fig. 1B, C). At this time, telencephalon micro-
vessels emanate a few vessel sprouts which are revealed by
typical CD31?/CD105? endothelial tip cells, with abun-
dant, long filopodial extensions and CD31/CD105 labelled
MVs (Fig. 1C, D). Later on, at 22 wg, as a consequence of
brain size increase and cerebral cortex development, an
active phase of vascular branching is seen to start, firstly in
the subcortical brain layers. At this time, the CD31 staining
pattern is junctional in parental vessels and at the origin of
the sprout stalk, whereas it is diffusely cytoplasmic at the
sprout ending and marks tip cells together with tufts of
filopodial processes and associated MVs (Fig. 2A–C). On
favourably oriented sections, head-to-head vessel sprouts
are recognizable at various steps of the process growth
journey, while they grow to fill the gap between their
respective parental vessels, and finally fuse head-to-head to
form a new, patent, anastomotic collateral (Fig. 2A–C) (see
also Online Resource 1).
On double labelled CD31/NG2 sections, growing
microvessels appear enveloped by NG2? pericytes
(Fig. 2D–G) and the target-oriented filopodia emerge from
the pericyte envelope, and elongate in the surrounding
neuropil with accompanying MVs (Fig. 2D–G). At the
sprout tip MVs bud off from the endothelial tip cell plasma
membrane close to the filopodial base, and maintain this
contact at a distance from their origin throughout the filo-
podial length (Fig. 2F, H). An accurate analysis of endo-
thelial-derived filopodia/MVs shows further details on these
cellular apparatus, a few MVs and short filopodia being
recognizable along the sprout stalk formed by activated,
proliferating endothelial cells, whereas a larger number of
MVs associated with numerous, long filopodial extensions
are concentrated around the tip endothelial cells (Fig. 3A–
F). The growing sprouts are also revealed by endoglin/
CD105, that reveals angiogenically activated endothelial tip
cells, their filopodia and associated MVs (Fig. 4A, C). On
double immunolabellings with CD105 and collagen IV, the
tip cell endothelial filopodia/MVs apparatus is free from the
remaining collagen IV basement membrane and projects
into the surrounding neuropil (Fig. 4B, D). Tip cell MVs
labelled by both CD31 and CD105 have an estimated mean
diameter of 717.02 ± 130.01 nm (743.64 ± 138.93 at
9–10 wg and 702.12 ± 125.16 at 22 wg) measured on sin-
gle optical planes from projection stacks at suitable inter-
vals, as shown in the animation (Online Resource 2).
Ultrastructural appearance of endothelial tip cells and
filopodia is revealed by TEM analysis (Fig. 5). The luminal
and the abluminal sides of vascular sprouts are irregular and
the vessel lumen is narrow or absent; the endothelial cells are
characterized by electron-dense cytoplasm, the tip cell large
nucleus is positioned at the leading front (Fig. 5A, B). At this
site, filopodial processes rich in bundles of microfilaments
are seen to emerge from a large base, which contains mul-
tivesicular body-like structures and polysomes (Fig. 5A0,
B0). Perivascular astroglia endfeet, revealed by their elec-
tron-lucent cytoplasm containing glycogen granules, are
seen in contact with endothelial tip cells (Fig. 5A0, B0).
Angiogenesis is well known to be under the control of
several growth factors, receptors, co-factors and enzyme
systems, all involved in a complex and finely tuned balance
between pro- and anti-angiogenic effects (reviewed in
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[12–16]). At the beginning of cerebral cortex vasculariza-
tion, early penetrating microvessels elongate and start to put
out primary branches close to the VZ, subsequent waves of
radial microvessels penetrate the nerve wall and at midg-
estation a remarkable phase of vessel branching is revealed
by the presence of several sites of vascular budding and
sprouting in the subcortical layers. The results show that
during these phases of foetal brain vascularization activated
endothelial cells are characterized by filopodial processes
and plasma membrane-derived MVs. At the sprouting front,
endothelial tip cells send out CD31/CD105 MVs, which
appear to run free in the tip cell vicinity or to be associated
with endothelial filopodia. This conveyor/messenger tip cell
apparatus may be involved in the process of vascular
growth, branching and anastomosis, transporting quanta of
active molecules along a controlled path towards a vascular
target. According to this hypothesis, the observed end-to-
end mode of branching could be mutually regulated, vessel
Fig. 1 Confocal microscopy image of human foetal telencephalon at
9–10 wg, double labelled with CD31/NG2 (A–C) and CD105/NG2
(D). A Periventricular microvessels close to the ventricular zone (VZ)
show CD31? endothelial cells surrounded by activated, NG2?
pericytes; endothelial filopodia are sent out to the ventricle (arrows).
B Two microvessels with well distinguishable NG2? pericytes
(arrowheads) and filopodia and MVs recognizable in the neuropil
between them (arrows). C A growing sprout is shown with well
developed spider web-like filopodia and a high number of associated
MVs (see also the inset). D A typical CD105? endothelial tip cell
with a tuft of filopodia that pass through the NG2 cover (arrowhead)
and appear associated to MVs at various distances from the sprout tip
front (arrows). Scale bars = A, C 10 lm; B 15 lm; D 7.5 lm
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sprouts being able to orientate one another by shedding MVs
associated to guiding filopodia. A possible mechanism of
‘tentacle recognition’ was firstly described by Thomas Ba¨r,
on the basis of his observations on ink-injected specimens
and electron microscopy preparations, and illustrated in a
diagram (kindly provided by Prof. J.R. Wolff), where he
described ‘‘A fusion of capillary sprouts with preexisting
capillaries or with another sprout may be initiated by contact
of small endothelial tentacles’’ [17] and Online Resource 3.
Recently, tip cells that meet and fuse, forming capillary
loops, have been revealed by time-lapse confocal micros-
copy [18]. In this scenario, shed vesicles may mediate
multiple biological processes by horizontal transfer of pro-
teins and RNAs [19], by releasing their molecular content
close to or directly into the recipient cells, endothelial and/or
perivascular cells (pericytes, astrocytes), or by delivering
membrane-associated molecules, as in the case of endoglin/
CD105 that, through interactions with the TGF-b receptors,
affects TGF-b responses, finally modulating endothelial cell
proliferation, differentiation, and migration (reviewed in
Fig. 2 Confocal microscopy image of human foetal telencephalon at
22 wg, single labelled with CD31 (A–C, H) and double labelled with
CD31/NG2 (D–G). A–C Different steps in vascular sprout growth
and elongation (A) and in head-to-head vessel sprouting (B, C); note
in C the fusion of two sprouts (arrows). D, E, G CD31 labelled
growing microvessels enveloped by NG2? pericytes; in E and G
(two enlargements of picture D) sprout tips decorated by numerous
filopodial processes (arrowheads). F, H Frontal view of the sprouting
tip cell with filopodia and MVs, the latter also associated (H, green
channel of F) with the filopodia base (arrows). Scale bars A,
E 10 lm; B 15 lm; C, D 20 lm; F, H 7.5 lm
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Fig. 3 Confocal microscopy image of human foetal telencephalon at
22 wg, single labeled with CD31. Short filopodia and isolated MVs
are released from the entire length of the vessel stalk, whereas long
filopodia and numerous MVs originate from the tip cell; relationships
of MVs and vessel wall are better shown by a zoomed single optical
plane (B) from the stack of optical planes (A). Scale bars A 15 lm;
B, C 10 lm; D, F 5 lm; E 7.5 lm
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[20]). The detection at the tip cell leading edge of mul-
tivesicular bodies, which have been suggested to be
involved in the origin of cell membrane-derived vesicular
structures (reviewed in [21]), supports the idea that an het-
erogeneous population of membrane vesicles, included the
described MVs associated with tip cell filopodia, may rep-
resent a component of a specialized tip cell site for cell-to-
cell communication. After these preliminary observations
carried out on human brain vascularization, we can only
presume that similar mechanisms may be involved in
angiogenesis in different CNS regions and in other species
since, to the best of our knowledge, MVs associated to
endothelial tip cell filopodia have been barely described. In
developing retina, one of the most widely used models for
investigation of CNS physiological and pathological angi-
ogenesis, characteristic swellings similar to membrane-
associated MVs have been shown at the end of tip cell filo-
podial extension in VEGF120 transgenic mice [22].
The next goal of this research project will be to devise
immunohistochemical/confocal and electron microscopy
protocols for ‘in situ’ testing of a number of growth
factors and related molecules involved in MV-mediated
Fig. 4 Confocal microscopy image of human foetal telencephalon at
22 wg, single labelled with CD105 (A, C) and double labelled with
CD105/collagen IV (B, D). A, C Tip cells, tufts of filopodia and
associated MVs are revealed by the endothelial proliferation marker
CD105; note in C shed MVs associated with filopodia far from the tip
cell (arrowheads). B, D The profile (B) and the frontal view (D) of
CD105? endothelial filopodia and MVs, which emerge from the
collagen IV basal lamina. Scale bars A–D 5 lm
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Fig. 5 Transmission electron microscopy of human foetal telenceph-
alon at 9–10 wg. A, B Two vascular sprouts with endothelial tip cells
(ETC.) and emerging filopodial processes (arrows); note in B a
nucleated blood cell within the narrow vascular lumen. A’, B’ Higher
magnification of vascular sprouts (depicted in A and B) shows details
of endothelial tip cells (ETC.): A’ filopodial emergence and tip cell-
contacting astroglia endfeet (asterisks), B’ multivesicular body-like
structures (mvb) at the base of a drumstick shaped filopodial process
(arrowheads). Scale bars A 5 lm; B 2 lm; A’ 1.5 lm; B’ 400 nm
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cell-to-cell communication during normal human brain
angiogenesis.
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